PT1119359E - Formulacao de 2-metil-tieno-benzodiazepina - Google Patents

Formulacao de 2-metil-tieno-benzodiazepina

Info

Publication number
PT1119359E
PT1119359E PT99915009T PT99915009T PT1119359E PT 1119359 E PT1119359 E PT 1119359E PT 99915009 T PT99915009 T PT 99915009T PT 99915009 T PT99915009 T PT 99915009T PT 1119359 E PT1119359 E PT 1119359E
Authority
PT
Portugal
Prior art keywords
formulation
tiene
benzodiazepine
methyl
olanzapine
Prior art date
Application number
PT99915009T
Other languages
English (en)
Portuguese (pt)
Inventor
David Edward Tupper
Barry Arnold Hendriksen
Charles Arthur Bunnell
Thomas Harry Ferguson
Manuel Vicente Sanchez-Felix
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1119359E publication Critical patent/PT1119359E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT99915009T 1998-09-30 1999-03-24 Formulacao de 2-metil-tieno-benzodiazepina PT1119359E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
PT1119359E true PT1119359E (pt) 2004-08-31

Family

ID=26859927

Family Applications (2)

Application Number Title Priority Date Filing Date
PT99915009T PT1119359E (pt) 1998-09-30 1999-03-24 Formulacao de 2-metil-tieno-benzodiazepina
PT04005832T PT1468689E (pt) 1998-09-30 1999-03-24 Formulação de 2-metil-tieno-benzodiazepina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT04005832T PT1468689E (pt) 1998-09-30 1999-03-24 Formulação de 2-metil-tieno-benzodiazepina.

Country Status (28)

Country Link
EP (1) EP1119359B1 (enExample)
JP (1) JP4551988B2 (enExample)
CN (1) CN1146422C (enExample)
AT (2) ATE359793T1 (enExample)
AU (1) AU759751B2 (enExample)
BR (1) BR9914156A (enExample)
CA (1) CA2344873A1 (enExample)
CZ (1) CZ302367B6 (enExample)
DE (2) DE69935873T2 (enExample)
DK (2) DK1468689T3 (enExample)
EA (1) EA002580B1 (enExample)
ES (2) ES2221376T3 (enExample)
GE (1) GEP20094818B (enExample)
HK (1) HK1041199B (enExample)
HR (1) HRP20010238B1 (enExample)
HU (1) HU227400B1 (enExample)
ID (1) ID29574A (enExample)
IL (2) IL141766A0 (enExample)
MY (1) MY126476A (enExample)
NO (1) NO328243B1 (enExample)
NZ (1) NZ510208A (enExample)
PL (1) PL196821B1 (enExample)
PT (2) PT1119359E (enExample)
SK (1) SK285944B6 (enExample)
TR (1) TR200100885T2 (enExample)
TW (1) TW577890B (enExample)
UA (1) UA66872C2 (enExample)
WO (1) WO2000018408A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1246827E (pt) * 1999-12-28 2005-08-31 Cipla Ltd Novas formas polimerficas da olanzapina
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
EP1781666A1 (en) * 2004-07-14 2007-05-09 Shasun Chemicals and Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
EP2623095A1 (en) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
EP1838716B1 (en) * 2005-01-05 2011-06-01 Eli Lilly And Company Olanzapine pamoate dihydrate
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
JP5486690B2 (ja) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
US9469630B2 (en) 2010-10-18 2016-10-18 Sumitomo Dainippon Pharma Co., Ltd. Sustained-release formulation for injection
EP2956456B1 (en) 2013-02-13 2017-07-12 Neuland Laboratories Ltd A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
EP3600258A1 (en) 2017-03-20 2020-02-05 Teva Pharmaceuticals International GmbH Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA933134B (en) * 1992-05-08 1993-11-30 Akzo Nv Depot preparation
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
AU720366B2 (en) * 1996-09-23 2000-06-01 Eli Lilly And Company Olanzapine dihydrate D
AU752552C (en) * 1997-09-30 2003-09-11 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation

Also Published As

Publication number Publication date
MY126476A (en) 2006-10-31
NO20011583L (no) 2001-03-28
HUP0103636A3 (en) 2003-05-28
DE69935873D1 (de) 2007-05-31
HRP20010238B1 (en) 2006-05-31
NZ510208A (en) 2003-04-29
EA200100406A1 (ru) 2001-10-22
NO328243B1 (no) 2010-01-11
TR200100885T2 (tr) 2001-08-21
ATE267602T1 (de) 2004-06-15
EA002580B1 (ru) 2002-06-27
EP1119359B1 (en) 2004-05-26
PL196821B1 (pl) 2008-02-29
WO2000018408A1 (en) 2000-04-06
GEP20094818B (en) 2009-11-10
HK1041199B (en) 2005-03-18
CN1320038A (zh) 2001-10-31
ES2221376T3 (es) 2004-12-16
DE69917663T2 (de) 2005-05-25
NO20011583D0 (no) 2001-03-28
EP1119359A4 (en) 2001-12-19
CZ20011149A3 (cs) 2002-01-16
IL141766A0 (en) 2002-03-10
CA2344873A1 (en) 2000-04-06
HRP20010238A2 (en) 2002-04-30
ATE359793T1 (de) 2007-05-15
PL346981A1 (en) 2002-03-11
DE69935873T2 (de) 2008-01-10
JP2002525330A (ja) 2002-08-13
DK1468689T3 (da) 2007-08-13
AU759751B2 (en) 2003-05-01
SK285944B6 (sk) 2007-11-02
HUP0103636A2 (hu) 2002-01-28
BR9914156A (pt) 2001-06-26
ID29574A (id) 2001-09-06
CN1146422C (zh) 2004-04-21
DK1119359T3 (da) 2004-08-16
ES2285294T3 (es) 2007-11-16
JP4551988B2 (ja) 2010-09-29
CZ302367B6 (cs) 2011-04-13
HK1041199A1 (en) 2002-07-05
HU227400B1 (en) 2011-05-30
IL141766A (en) 2006-12-31
DE69917663D1 (de) 2004-07-01
PT1468689E (pt) 2007-07-09
TW577890B (en) 2004-03-01
SK4162001A3 (en) 2002-03-05
AU3362799A (en) 2000-04-17
EP1119359A1 (en) 2001-08-01
UA66872C2 (uk) 2004-06-15

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
ATE359793T1 (de) 2-methyl-thieno-benzodiazepin formulierung
ES2180899T3 (es) Dihidrato d de olanzapina.
NO20010556L (no) Fremgangsmate for oftalmisk administrering
EA199900373A2 (ru) Фармацевтические композиции
YU15299A (sh) Farmaceutski sastavi
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
NL1006065A1 (nl) Inlegkruisje voor stringslip.
IT1307928B1 (it) Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
ZA989997B (en) Compositions of lipid lowering agents.
DK1073447T3 (da) N1-modificerede glycopeptider
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
EE04750B1 (et) HIV-proteaasi inhibiitorite valmistamismeetod
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
ITBO970720A0 (it) Procedimento per il trattamento di tessuti.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.
IT1282956B1 (it) Procedimento per la preparazione di un azetidinone
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide